UBS Group’s InflaRx IFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.6K | Sell |
29,800
-4,917
| -14% | -$4.64K | ﹤0.01% | 7764 |
|
|
2025
Q4 | $35.1K | Buy |
34,717
+12,296
| +55% | +$15.3K | ﹤0.01% | 7427 |
|
|
2025
Q3 | $30K | Buy |
22,421
+14,326
| +177% | +$15.2K | ﹤0.01% | 7896 |
|
|
2025
Q2 | $6.39K | Buy |
+8,095
| New | +$9.57K | ﹤0.01% | 9096 |
|
|
2025
Q1 | – | Sell |
-67,441
| Closed | -$167K | – | 10458 |
|
|
2024
Q4 | $167K | Buy |
+67,441
| New | +$130K | ﹤0.01% | 6565 |
|
|
2023
Q4 | – | Sell |
-463
| Closed | -$1.38K | – | 9575 |
|
|
2023
Q3 | $1.38K | Buy |
+463
| New | +$1.76K | ﹤0.01% | 7958 |
|
|
2023
Q1 | – | Sell |
-504
| Closed | -$1.56K | – | 9934 |
|
|
2022
Q4 | $1.56K | Sell |
504
-4,857
| -91% | -$12.4K | ﹤0.01% | 9841 |
|
|
2022
Q3 | $14K | Buy |
+5,361
| New | +$12.1K | ﹤0.01% | 7907 |
|
|
2022
Q2 | – | Sell |
-2,481
| Closed | -$5K | – | 10594 |
|
|
2022
Q1 | $5K | Sell |
2,481
-2,011
| -45% | -$6.26K | ﹤0.01% | 9128 |
|
|
2021
Q4 | $21K | Sell |
4,492
-523
| -10% | -$2.1K | ﹤0.01% | 7779 |
|
|
2021
Q3 | $13K | Buy |
5,015
+3,770
| +303% | +$9.93K | ﹤0.01% | 7665 |
|
|
2021
Q2 | $4K | Sell |
1,245
-5,284
| -81% | -$17.5K | ﹤0.01% | 8669 |
|
|
2021
Q1 | $25K | Buy |
6,529
+4,583
| +236% | +$23.5K | ﹤0.01% | 7171 |
|
|
2020
Q4 | $10K | Buy |
1,946
+77
| +4% | +$347 | ﹤0.01% | 7485 |
|
|
2020
Q3 | $8K | Buy |
1,869
+496
| +36% | +$2.28K | ﹤0.01% | 7011 |
|
|
2020
Q2 | $6K | Sell |
1,373
-1,012
| -42% | -$6.56K | ﹤0.01% | 7295 |
|
|
2020
Q1 | $9K | Buy |
+2,385
| New | +$8.83K | ﹤0.01% | 6990 |
|
|
2019
Q4 | – | Sell |
-1,124
| Closed | -$3K | – | 8249 |
|
|
2019
Q3 | $3K | Buy |
+1,124
| New | +$3.27K | ﹤0.01% | 7633 |
|
|
2019
Q2 | – | Sell |
-449
| Closed | -$17K | – | 7991 |
|
|
2019
Q1 | $17K | Buy |
+449
| New | +$16.7K | ﹤0.01% | 6432 |
|
|
2018
Q4 | – | Sell |
-2,442
| Closed | -$84K | – | 8148 |
|
|
2018
Q3 | $84K | Sell |
2,442
-2,639
| -52% | -$85.1K | ﹤0.01% | 5734 |
|
|
2018
Q2 | $164K | Buy |
5,081
+5,002
| +6,332% | +$173K | ﹤0.01% | 5094 |
|
|
2018
Q1 | $2K | Sell |
79
-994
| -93% | -$26.2K | ﹤0.01% | 7534 |
|
|
2017
Q4 | $22K | Buy |
+1,073
| New | +$19.4K | ﹤0.01% | 6477 |
|
Other funds holding IFRX
SCM
6CM
EP
TC
UBS Group's IFRX Position: Q1 2026 in Review
UBS Group reduced its InflaRx (IFRX) stake by 14% in Q1 2026, selling an estimated $4.64K and leaving 29,800 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7764.
UBS Group first reported a position in IFRX in Q4 2017 and has held it in 23 quarters since. The position peaked at $167K in Q4 2024. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.
- UBS Group held 29,800 shares of InflaRx worth $26.6K as of Q1 2026.
- UBS Group sold 4,917 InflaRx shares in Q1 2026, an estimated $4.64K.
- InflaRx made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7764 holding.
- UBS Group first reported a position in InflaRx in Q4 2017 and has held it in 23 quarters since.
- UBS Group's InflaRx position peaked at $167K in Q4 2024.
- 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.